Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 077571
Company: SUN PHARM INDS INC
Company: SUN PHARM INDS INC
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| REPAGLINIDE | REPAGLINIDE | 0.5MG | TABLET; ORAL | None (Tentative Approval) | None | No | No |
| REPAGLINIDE | REPAGLINIDE | 1MG | TABLET;ORAL | Discontinued | None | No | No |
| REPAGLINIDE | REPAGLINIDE | 2MG | TABLET;ORAL | Discontinued | None | No | No |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 07/11/2013 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/077571s000lbl.pdf |